Sponsor intelligence · OTHER
Clinical trials sponsored by
Peking University Cancer Hospital & Institute.
Real, source-linked trial activity for Peking University Cancer Hospital & Institute: 7 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 5, 2026. Source-linked, daily-refreshed.
PHASE2 4NA 1PHASE4 1N/A 1
Newest Peking University Cancer Hospital & Institute trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Application of Generative Artificial Intelligence in Perioperative Per | NA | ENROLLING_BY_INVITATION | ↗ |
| 16d ago | SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizum | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 34d ago | A Study of QL1706 Combined With OH2 Injection in Perioperative Treatme | Ph 4 | NOT_YET_RECRUITING | ↗ |
| 37d ago | Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuc | Ph 2 | RECRUITING | ↗ |
| 38d ago | Trastuzumab Rezetecan Plus Bevacizumab in Platinum-Sensitive Recurrent | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 44d ago | Local Methylene Blue Injection for Prevention of Anastomotic Leakage a | Ph 2 | RECRUITING | ↗ |
| 50d ago | Risk of Esophageal Cancer Returning After Immunotherapy, Chemotherapy, | N/A | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Peking University Cancer Hospital & Institute (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.